EPIX ESSA PHARMA INC

Ownership history in TWO SIGMA ADVISERS, LP  ·  15 quarters on record

This page tracks every 13F SEC filing in which TWO SIGMA ADVISERS, LP reported a position in ESSA PHARMA INC (EPIX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2021 Q3)
Avg. % of fund
0.0%
First filed
2021 Q1
Last filed
2025 Q3
Quarters held
15
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 214,800 -46,000 -17.6% 0.00% $41K
2025 Q2 REDUCED 260,800 -15,300 -5.5% 0.00% $443K
2025 Q1 ADDED 276,100 +193,500 +234.3% 0.00% $436K
2024 Q4 ADDED 82,600 +25,700 +45.2% 0.00% $148K
2023 Q3 REDUCED 56,900 -25,400 -30.9% 0.00% $176K
2023 Q2 REDUCED 82,300 -141,500 -63.2% 0.00% $222K
2023 Q1 ADDED 223,800 +51,700 +30.0% 0.00% $665K
2022 Q4 REDUCED 172,100 -170,300 -49.7% 0.00% $434K
2022 Q3 ADDED 342,400 +291,300 +570.1% 0.00% $623K
2022 Q2 REDUCED 51,100 -61,900 -54.8% 0.00% $161K
5 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)
← Back to TWO SIGMA ADVISERS, LP Holdings